Table 2 ∣.
Replication cohort |
Patient no. |
Sex | Age (years) |
Hypertensive at pregnancy (number of pregnancies) |
Tumor genotype | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CTNNB1 |
GNA11 Q209 |
GNA11 R183 |
GNAQ Q209 |
GNAQ R183 |
GNAS Q227 |
GNAS R201 |
|||||
French cohort | F1 | Female | 29 | Yes (1) | S45F | WT | WT | WT | WT | WT | WT |
F2 | Male | 40 | – | S45P | WT | WT | WT | WT | WT | WT | |
F3 | Female | 35 | No (2) | S37C | WT | WT | WT | WT | WT | WT | |
F4 | Male | 33 | – | S45A | WT | WT | WT | WT | WT | WT | |
F5 | Female | 43 | No (1) | S45F | Q209P | WT | WT | WT | WT | WT | |
F6 | Female | 45 | Yes (2) | S45P | WT | WT | WT | WT | WT | WT | |
F7 | Female | 55 | NA | S45P | WT | WT | WT | WT | WT | WT | |
F8 | Female | 55 | NA | S45P | WT | WT | WT | WT | WT | WT | |
F9 | Female | 26 | Yesa (1) | S37P | WT | WT | Q209H | WT | WT | WT | |
F10 | Female | 51 | Yes (1) | S45P | Q209H | WT | WT | WT | WT | WT | |
F11 | Male | 36 | – | S45P | WT | WT | WT | WT | WT | WT | |
F12 | Female | 56 | No (10) | D32Y | Q209H | WT | WT | WT | WT | WT | |
F13 | Female | 56 | No (0) | S45Y | WT | WT | WT | WT | WT | WT | |
F14 | Female | 17 | Nob (0) | G34V | WT | WT | Q209H | WT | WT | WT | |
Swedish cohort | S1 | Female | 55 | Yesc (2) | S45P | WT | WT | Q209H | WT | WT | WT |
S2 | Female | 59 | NA | S45P | WT | WT | WT | WT | WT | WT | |
S3 | Female | 26 | NA | S37F | WT | WT | WT | WT | WT | WT |
WT, wild type.
Pre-eclampsia.
Hypertensive at puberty.
Onset at age 24 years preceding first pregnancy.